If you are still working according to traditional collagen stimulation protocols, you may be missing new opportunities for your patients. The industry has taken a significant step forward.
Recent fundamental studies (published in Nature and verified through PubMed) demonstrate that type XVII collagen is a key factor in anti-aging processes and advanced tissue regeneration.
What does this mean for your practice?
The introduction of type XVII collagen can increase the production of the body’s own type III collagen by 5 times and enhance the synthesis of type I collagen by 27 times.
This innovative technology is the foundation of Feijia Face&Body. It combines recombinant type III and type XVII collagen in a balanced formula.
Thanks to type XVII collagen, the process of natural neocollagenesis is activated, beginning from day 21 and continuing steadily for 4–6 months.
The result is tissue compaction and tightening without fibrosis, swelling, or excessive volume.